• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    32 Stocks Moving In Monday's Mid-Day Session

    1/31/22 12:01:02 PM ET
    $AKTS
    $AMPH
    $ANPC
    $API
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AKTS alert in real time by email

    Gainers

    • FGI Industries Ltd. (NASDAQ:FGI) shares jumped 42.4% to $5.37 after surging 19% on Friday. The company, last week, priced its IPO at $6 per share.
    • Knightscope, Inc. (NASDAQ:KSCP) gained 30% to $21.18 after jumping 175% on Friday. The company, last week, priced its IPO at $10 per share.
    • Bassett Furniture Industries, Incorporated (NASDAQ:BSET) shares climbed 28% to $17.90 after reporting Q4 results. J.B. Hunt agreed to acquire Zenith Freight Lines from Bassett for $87 million.
    • Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) gained 22.5% to $2.82 after the company announced it signed an exclusive summary distribution agreement with Glo-Med Networks for distribution across 6 states in the United States.
    • Arrival (NASDAQ:ARVL) gained 20% to $3.80.
    • Lordstown Motors Corp. (NASDAQ:RIDE) jumped 20% to $2.9450.
    • Hour Loop, Inc. (NASDAQ:HOUR) gained 19.9% to $3.3950.
    • Akoustis Technologies, Inc. (NASDAQ:AKTS) surged 17% to $5.91 after the company reported Q2 earnings results and announced five new Wi-Fi design wins.
    • Embark Technology, Inc. (NASDAQ:EMBK) rose 16.9% to $3.6950.
    • Genetron Holdings Limited (NASDAQ:GTH) gained 16.4% to $4.11. Genetron Health, earlier during the month, reiterated its FY21 revenue guidance.
    • TDCX Inc. (NYSE:TDCX) surged 16.3% to $15.55.
    • Agora, Inc. (NASDAQ:API) jumped 14.8% to $10.73.
    • Chindata Group Holdings Limited (NASDAQ:CD) gained 14.5% to $5.03.
    • Workhorse Group Inc. (NASDAQ:WKHS) jumped 14% to $3.3050.
    • Novan, Inc. (NASDAQ:NOVN) gained 13.3% to $3.59.
    • Ontrak, Inc. (NASDAQ:OTRK) surged 12.5% to $3.31.
    • Novavax, Inc. (NASDAQ:NVAX) shares rose 11.6% to $92.58. Novavax shares gained around 14% on Friday after the company announced a supply agreement to provide an initial 5 million COVID-19 vaccine doses to Israel.
    • NIO Inc. (NYSE:NIO) gained 11.5% to $23.33.
    • Cian PLC (NYSE:CIAN) rose 10.5% to $7.74 after jumping around 10% on Friday. Cian recently entered into an agreement for acquisition of SmartDeal.
    • Exela Technologies, Inc. (NASDAQ:XELA) rose 9.6% to $0.6900 after jumping 15% on Friday. Exela Technologies recently announced a share buyback of up to 100 million shares of common stock at $1 per share through an exchange offer of new notes.
    • Ideanomics, Inc. (NASDAQ:IDEX) rose 9.1% to $0.9960.
    • WISeKey International Holding AG (NASDAQ:WKEY) shares gained 8.8% to $3.5360. WISeKey reported full year 2021 preliminary results with revenue of $22.2 million.
    • Mechel PAO (NYSE:MTL) rose 7% to $2.91.
    • AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) shares rose 6.4% to $0.7766 after dropping around 4% on Friday.

    Also check out these big insider trades here

    Losers

    • Imperial Petroleum Inc. (NASDAQ:IMPP) shares dipped 52.3% to $1.0401 after the company reported pricing of upsized $12 million underwritten public offering.
    • Eros STX Global Corporation (NYSE:ESGC) shares fell 32.6% to $0.1926. ErosSTX reported a reverse stock split.
    • AppHarvest, Inc. (NASDAQ:APPH) fell 15.7% to $2.8650. AppHarvest reported preliminary FY21 net sales and non-GAAP Adjusted EBITDA at the higher end of guidance.
    • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) fell 10.8% to $2.78. NRx Pharmaceuticals reported $25 million private placement priced at a premium to market under Nasdaq rules.
    • Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) dropped 10.5% to $23.33.
    • Merida Merger Corp. I (NASDAQ:MCMJ) dipped 10% to $6.45.
    • Williams Industrial Services Group Inc. (NYSE:WLMS) fell 9.7% to $1.8950. Williams Industrial Services Group recently issued FY22 guidance with a midpoint below consensus estimates.
    • Fathom Digital Manufacturing Corporation (NYSE:FATH) dropped 7.4% to $8.81. Needham recently initiated coverage on Fathom Digital with a Buy rating and announced a price target of $12.

    Also check: Executives buy around $88 million of four stocks

    Get the next $AKTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKTS
    $AMPH
    $ANPC
    $API

    CompanyDatePrice TargetRatingAnalyst
    Amphastar Pharmaceuticals Inc.
    $AMPH
    4/21/2026$22.00Buy → Hold
    Jefferies
    NIO Inc.
    $NIO
    3/13/2026$6.80Hold → Buy
    HSBC Securities
    NIO Inc.
    $NIO
    3/11/2026$6.60Neutral → Buy
    Nomura
    Aktis Oncology Inc.
    $AKTS
    3/9/2026$30.00Buy
    H.C. Wainwright
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$30.00Overweight
    Analyst
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$34.00Buy
    BofA Securities
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$31.00Outperform
    Leerink Partners
    Aktis Oncology Inc.
    $AKTS
    2/3/2026Buy
    TD Cowen
    More analyst ratings

    $AKTS
    $AMPH
    $ANPC
    $API
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Foley Todd converted options into 4,002,533 shares and bought $4,191,660 worth of shares (232,870 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:20:21 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Mpm Bioventures 2018, L.P. converted options into 8,805,578 shares and bought $20,029,986 worth of shares (1,112,777 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:19:26 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Gadicke Ansbert converted options into 8,805,578 shares and bought $20,029,986 worth of shares (1,112,777 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:17:54 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $AMPH
    $ANPC
    $API
    SEC Filings

    View All

    FGI Industries Ltd. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - FGI Industries Ltd. (0001864943) (Filer)

    4/23/26 4:12:56 PM ET
    $FGI
    Industrial Specialties
    Industrials

    Workhorse Group Inc. filed SEC Form 8-K: Other Events

    8-K - Workhorse Group Inc. (0001425287) (Filer)

    4/23/26 4:07:33 PM ET
    $WKHS
    Auto Manufacturing
    Industrials

    Bassett Furniture Industries Incorporated filed SEC Form 8-K: Leadership Update

    8-K - BASSETT FURNITURE INDUSTRIES INC (0000010329) (Filer)

    4/21/26 2:09:57 PM ET
    $BSET
    Home Furnishings
    Consumer Discretionary

    $AKTS
    $AMPH
    $ANPC
    $API
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Rozanovich Yoav

    3 - Inspira Technologies OXY B.H.N. Ltd (0001837493) (Issuer)

    4/23/26 7:45:16 AM ET
    $IINN
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Walker Robert Edward

    4 - NOVAVAX INC (0001000694) (Issuer)

    4/16/26 6:13:00 PM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Walker Robert Edward

    3 - NOVAVAX INC (0001000694) (Issuer)

    4/16/26 5:40:20 PM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AKTS
    $AMPH
    $ANPC
    $API
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for MEDROXYPROGESTERONE ACETATE issued to AMPHASTAR PHARMS INC

    Submission status for AMPHASTAR PHARMS INC's drug MEDROXYPROGESTERONE ACETATE (SUPPL-5) with active ingredient MEDROXYPROGESTERONE ACETATE has changed to 'Approval' on 01/25/2024. Application Category: ANDA, Application Number: 077334, Application Classification: Labeling

    1/26/24 4:40:02 AM ET
    $AMPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $AMPH
    $ANPC
    $API
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Senmiao Technology Appoints David Nichols as Strategic Advisor to Advance AI Data Center, Digital Infrastructure, and New Energy Strategy

    Veteran Infrastructure Finance and Carbon Markets Executive Brings Public Company Leadership, Hyperscale Data Center Development, and Capital Markets Structuring Expertise to AIHS Growth Platform Chengdu, China, April 23, 2026 (GLOBE NEWSWIRE) -- Senmiao Technology Limited ("Senmiao" or the "Company") (NASDAQ:AIHS) today announced the appointment of David Nichols as Strategic Advisor, effective immediately. In this role, Mr. Nichols will drive the Company's business development and strategic execution across its AI data center solutions, digital infrastructure, and new energy initiatives, with a particular focus on power infrastructure origination, capital formation, and institutional pa

    4/23/26 8:00:00 AM ET
    $AIHS
    $APPH
    Finance: Consumer Services
    Finance
    Farming/Seeds/Milling
    Consumer Staples

    Agora and thymia Partner to Enable Real-Time Health and Safety Intelligence Across Voice Communications

    SANTA CLARA, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Agora (NASDAQ:API), a global leader in real-time engagement and conversational AI, today announced a strategic partnership with thymia, the human state voice intelligence company that has built the first clinically validated infrastructure for reading the complete signal carried in voice - and acting on it in real-time. The partnership brings together Agora's global, low-latency real-time conversational AI infrastructure and thymia's clinically validated voice intelligence layer. Together, they enable a new class of voice applications that understand the human state during live interactions, delivering both safety and commercial valu

    4/22/26 9:00:00 AM ET
    $API
    Computer Software: Prepackaged Software
    Technology

    WISeKey's SEALCOIN Launches "Spacedrop" for the Machine-driven Economy

    SEALCOIN Advances Infrastructure for the Machine Economy, Leveraging Hedera Network and Post-Quantum Cryptography Expertise Zug, Switzerland - April 22, 2026 — WISeKey International Holding Ltd ("WISeKey") ((SIX: WIHN, NASDAQ:WKEY), a leading global cybersecurity, blockchain, and IoT company, today announces that its subsidiary, SEALCOIN AG, Swiss-headquartered DEPIN (Decentralized Physical Infrastructure Network) entity revolutionizing the Internet of things and machine to machine economies' landscape, with strategic funding and technical support from The Hashgraph Association, today announced the launch of "Spacedrop", an early-access onboarding initiative that allows users to interact

    4/22/26 9:00:00 AM ET
    $LAES
    $WKEY
    Semiconductors
    Technology
    EDP Services

    $AKTS
    $AMPH
    $ANPC
    $API
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Amphastar Pharmaceuticals downgraded by Jefferies with a new price target

    Jefferies downgraded Amphastar Pharmaceuticals from Buy to Hold and set a new price target of $22.00

    4/21/26 7:28:58 AM ET
    $AMPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NIO upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded NIO from Hold to Buy and set a new price target of $6.80

    3/13/26 8:42:10 AM ET
    $NIO
    Auto Manufacturing
    Industrials

    NIO upgraded by Nomura with a new price target

    Nomura upgraded NIO from Neutral to Buy and set a new price target of $6.60

    3/11/26 8:29:36 AM ET
    $NIO
    Auto Manufacturing
    Industrials

    $AKTS
    $AMPH
    $ANPC
    $API
    Leadership Updates

    Live Leadership Updates

    View All

    Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors

    BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the "Company"), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced the appointment of Glenn Gormley, MD, PhD, as an independent director to its Board of Directors and co-chair of the Company's newly established Science and Technology Committee of the Board of Directors. "We are delighted to welcome Glenn to our Board as we continue to make significant progress toward upcoming clinical and corporate milestones," said Matthew Roden, PhD, President a

    4/16/26 8:00:00 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion

    RA'ANANA, Israel, April 14, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd (NASDAQ:IINN, IINNW)) ("Inspira Technologies" or the "Company") today announced the appointment of Mr. Yoav Rozanovich as Chief Business Officer ("CBO") of Inspira Technologies, reinforcing its commercial execution capabilities following its expansion into quantum computing connectivity and the acquisition of the Additive Manufacturing of Electronics ("AME") business from Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension"). Proven Commercial LeadershipMr. Rozanovich brings international experience across additive manufacturing, advanced electronics, and complex systems integration. From November 2021

    4/14/26 8:01:00 AM ET
    $IINN
    $NNDM
    $SSYS
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology

    NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer

    Mr Tyson has both clinical experience treating patients with serious mental health disorders and 25 years of successful industry commercial experience in the development and sales of medications in this fieldMr. Tyson is appointed as NRx anticipates approval of an ANDA for preservative-free ketamine and near term submission of a New Drug Application to expand ketamine labeling to encompass depression and suicidality. WILMINGTON, Del., April 13, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a biopharmaceutical company that focuses on neuroplastic therapies for depression, PTSD, and related conditions, today announces the appointment of Glenn Tyson as the company's first

    4/13/26 7:00:00 AM ET
    $NRXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $AMPH
    $ANPC
    $API
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Exela Technologies Inc.

    SC 13D/A - Exela Technologies, Inc. (0001620179) (Subject)

    12/3/24 4:01:40 PM ET
    $XELA
    Business Services
    Consumer Discretionary

    SEC Form SC 13D filed by Exela Technologies Inc.

    SC 13D - Exela Technologies, Inc. (0001620179) (Subject)

    11/27/24 5:57:16 PM ET
    $XELA
    Business Services
    Consumer Discretionary

    SEC Form SC 13D filed by Exela Technologies Inc.

    SC 13D - Exela Technologies, Inc. (0001620179) (Subject)

    11/27/24 4:00:55 PM ET
    $XELA
    Business Services
    Consumer Discretionary

    $AKTS
    $AMPH
    $ANPC
    $API
    Financials

    Live finance-specific insights

    View All

    FGI INDUSTRIES ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

    EAST HANOVER, N.J., April 9, 2026 /PRNewswire/ -- FGI Industries Ltd. (NASDAQ:FGI) ("FGI" or the "Company"), a leading global supplier of kitchen and bath products, today announced results for the fourth quarter and full-year 2025. FOURTH QUARTER 2025 HIGHLIGHTS(As compared to the fourth quarter of 2024)Total revenue of $30.5 million, -14.4% y/yGross profit of $8.1 million, -6.8% y/yGross margin of 26.7%, +210 bps y/yOperating loss of $0.7 million and net loss attributable to shareholders of $2.6 millionAdjusted operating loss of $0.7 million1Adjusted net loss of $0.6 millionFUL

    4/9/26 4:15:00 PM ET
    $FGI
    Industrial Specialties
    Industrials

    FGI INDUSTRIES ANNOUNCES FOURTH QUARTER AND FULL-YEAR RESULTS CONFERENCE CALL DATE

    EAST HANOVER, N.J., April 6, 2026 /PRNewswire/ -- FGI Industries Ltd. (NASDAQ:FGI) ("FGI" or the "Company"), a leading global supplier of kitchen and bath products, today announced that it will issue financial results for the fourth quarter and full-year 2025 after the market close on Thursday, April 9, 2026. Management will conduct a conference call on Friday, April 10, 2026, at 9:00 am Eastern Time to discuss the quarterly and full-year results. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of the C

    4/6/26 6:31:00 PM ET
    $FGI
    Industrial Specialties
    Industrials

    Inspira Technologies Announces Acquisition of the AME Platform from Nano Dimension

    The transaction includes intellectual property, customer-related assets and commercial operations, positioning the Company for the next stage of its strategy Further strategic update to follow shortly RA'ANANA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) ("Inspira" or the "Company"), today announced the acquisition of Nano Dimension Ltd.'s (NASDAQ:NNDM) ("Nano Dimension") AME platform. The acquired platform includes intellectual property, proprietary high-precision 3D electronic printing systems, patented software, engineering know-how, manufacturing equipment, inventory, customer-related assets, and fully equipped facilities, includin

    4/6/26 8:31:00 AM ET
    $IINN
    $NNDM
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology